7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study

      Preprint
      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          In January 2022, United States guidelines shifted to recommend isolation for 5 days from symptom onset, followed by 5 days of mask wearing. However, viral dynamics and variant and vaccination impact on culture conversion are largely unknown.

          Methods

          We conducted a longitudinal study on a university campus, collecting daily anterior nasal swabs for at least 10 days for RT-PCR and culture, with antigen rapid diagnostic testing (RDT) on a subset. We compared culture positivity beyond day 5, time to culture conversion, and cycle threshold trend when calculated from diagnostic test, from symptom onset, by SARS-CoV-2 variant, and by vaccination status. We evaluated sensitivity and specificity of RDT on days 4–6 compared to culture.

          Results

          Among 92 SARS-CoV-2 RT-PCR positive participants, all completed the initial vaccine series, 17 (18.5%) were infected with Delta and 75 (81.5%) with Omicron. Seventeen percent of participants had positive cultures beyond day 5 from symptom onset with the latest on day 12. There was no difference in time to culture conversion by variant or vaccination status. For the 14 sub-study participants, sensitivity and specificity of RDT were 100% and 86% respectively.

          Conclusions

          The majority of our Delta- and Omicron-infected cohort culture-converted by day 6, with no further impact of booster vaccination on sterilization or cycle threshold decay. We found that rapid antigen testing may provide reassurance of lack of infectiousness, though masking for a full 10 days is necessary to prevent transmission from the 17% of individuals who remain culture positive after isolation.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic

          Key Points Question What is the burden of depression symptoms among US adults during the coronavirus disease 2019 (COVID-19) pandemic compared with before COVID-19, and what are the risk factors associated with depression symptoms? Findings In this survey study that included 1441 respondents from during the COVID-19 pandemic and 5065 respondents from before the pandemic, depression symptom prevalence was more than 3-fold higher during the COVID-19 pandemic than before. Lower income, having less than $5000 in savings, and having exposure to more stressors were associated with greater risk of depression symptoms during COVID-19. Meaning These findings suggest that there is a high burden of depression symptoms in the US associated with the COVID-19 pandemic and that this burden falls disproportionately on individuals who are already at increased risk.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

            This review summarizes current knowledge about the transmission of SARS-CoV-2. Evidence-based policies and practices should incorporate the accumulating knowledge regarding SARS-CoV-2 transmission to help educate the public and slow spread of this virus.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021

              In late November 2021, an outbreak of Omicron SARS-CoV-2 following a Christmas party with 117 attendees was detected in Oslo, Norway. We observed an attack rate of 74% and most cases developed symptoms. As at 13 December, none have been hospitalised. Most participants were 30–50 years old. Ninety-six percent of them were fully vaccinated. These findings corroborate reports that the Omicron variant may be more transmissible, and that vaccination may be less effective in preventing infection compared with Delta.
                Bookmark

                Author and article information

                Journal
                medRxiv
                MEDRXIV
                medRxiv
                Cold Spring Harbor Laboratory
                05 April 2022
                : 2022.04.04.22273429
                Affiliations
                [1 ]Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, USA
                [2 ]Boston Medical Center, Boston, MA, USA
                [3 ]Department of Microbiology, Boston University School of Medicine, Boston, MA, USA
                [4 ]National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA
                [5 ]Graduate Medical Sciences, Boston University School of Medicine, Boston, MA, USA
                [6 ]Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
                [7 ]Boston University School of Public Health, Boston, MA, USA
                [8 ]Boston University Clinical Testing Laboratory, Boston, MA, USA
                [9 ]Boston University Student Health Services, Boston, MA, USA
                [10 ]Department of Global Health, Boston University School of Public Health, Boston, MA, USA
                [11 ]Center for Emerging Infectious Disease Research and Policy, Boston University, Boston, MA, USA
                [12 ]Boston University Precision Diagnostics Center, Boston University, Boston, MA, USA
                [13 ]BioInformatics Program, Boston University, Boston, MA, USA
                Author notes
                [*]

                Equal manuscript contributions

                [* ] Contact Information – Corresponding and Alternate Corresponding Authors: Tara C. Bouton, Boston University School of Medicine, Section of Infectious Diseases, 801 Massachusetts Ave, 2 nd Floor, Boston, MA 02119, John Connor, National Emerging Infectious Diseases Laboratories, 620 Albany Street, Boston, MA 02118
                Article
                10.1101/2022.04.04.22273429
                8996632
                35411341
                29348f9e-8c38-4bcb-b345-62e37bd4bf6e

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.

                History
                Categories
                Article

                sars-cov-2,covid-19,viral infection,infection dynamics,omicron

                Comments

                Comment on this article